TOTAL VOLUME:

$134.2b

24H VOL:

$130,522,377

24H TRANSACTIONS:

2,388,728,490

OPEN INTEREST:

$1,438,389,636

404,028

Markets across

30,214

events

MATCHED EVENTS:

2,681

PLATFORM COVERAGE:

5

Polymarket:

39%

VS.

Kalshi:

61%

BETA
Dashboards
Tour
All
Sports
Cienciano vs Montevideo City: First Half Spread
kalshi

Cienciano vs Montevideo City: First Half Spread

Volume:
$6,201

Cienciano wins the 1H by more than 1.5 goals

 - Kalshi

Cienciano wins the 1H by more than 1.5 goals - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Sep 11, 2026

Closed: Sep 10, 9:22 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Cienciano wins the 1H by more than 1.5 goals

View
100%
Yes 100¢No 0¢
100¢
N/A
$5,108
N/A
N/A
$3,607
Settled
Yes
kalshi

Montevideo City wins the 1H by more than 1.5 goals

0%
Yes 0¢No 100¢
100¢
N/A
$1,093
N/A
N/A
$1,088
Settled
No
Total markets: 2

Description

This market focuses on predicting which team will dominate the first half of an upcoming soccer match by winning by a margin of more than 1.5 goals. It specifically tracks the performance of both teams in the initial 45 minutes of play, ignoring any events from the second half. The outcome depends solely on the goal difference during this period, with no consideration for the final match result.

Kalshi

The event determines whether either Cienciano or Montevideo City will secure a decisive lead in the first half of their CONMEBOL Sudamericana match scheduled for September 10, 2026, by winning by more than 1.5 goals. Two separate primary rules govern the resolution: one for Cienciano achieving this margin and another for Montevideo City doing the same. Both markets exclusively consider goals scored in the first half and disregard any scoring in the second half entirely. If the match is cancelled or rescheduled to more than 48 hours beyond the original date, the market resolves to a fair price, ensuring equitable treatment for all participants based on the available information up to that point.